Literature DB >> 2381198

Expressive language recovery in severely brain-injured children and adolescents.

T F Campbell1, C A Dollaghan.   

Abstract

The spontaneous expressive language abilities of 9 severely brain-injured children and adolescents and their age-matched normal controls were examined seven times over a 12-month period following injury. Analysis of conversational language samples revealed a relatively stable pattern of language performance for the normal subjects over this time interval. The brain-injured subjects, as a group, demonstrated improvement on the majority of measures, but only a few reached the level of their control subjects and interindividual variability was considerable. Results suggest that the prognosis for clinically significant improvement in severely brain-injured subjects is good; however, deficits in expressive skills remain apparent up to at least 12 months following injury.

Entities:  

Mesh:

Year:  1990        PMID: 2381198     DOI: 10.1044/jshd.5503.567

Source DB:  PubMed          Journal:  J Speech Hear Disord        ISSN: 0022-4677


  3 in total

1.  Recommendations for the use of common outcome measures in pediatric traumatic brain injury research.

Authors:  Stephen R McCauley; Elisabeth A Wilde; Vicki A Anderson; Gary Bedell; Sue R Beers; Thomas F Campbell; Sandra B Chapman; Linda Ewing-Cobbs; Joan P Gerring; Gerard A Gioia; Harvey S Levin; Linda J Michaud; Mary R Prasad; Bonnie R Swaine; Lyn S Turkstra; Shari L Wade; Keith O Yeates
Journal:  J Neurotrauma       Date:  2011-08-24       Impact factor: 5.269

2.  Persuasive discourse impairments in traumatic brain injury.

Authors:  Zahra Ghayoumi; Fariba Yadegari; Behrooz Mahmoodi-Bakhtiari; Esmaeil Fakharian; Mehdi Rahgozar; Maryam Rasouli
Journal:  Arch Trauma Res       Date:  2015-03-20

3.  Additional evidence for a therapeutic effect of dextromethorphan/quinidine on bulbar motor function in patients with amyotrophic lateral sclerosis: A quantitative speech analysis.

Authors:  Jordan R Green; Kristen M Allison; Claire Cordella; Brian D Richburg; Gary L Pattee; James D Berry; Eric A Macklin; Erik P Pioro; Richard A Smith
Journal:  Br J Clin Pharmacol       Date:  2018-10-01       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.